262 related articles for article (PubMed ID: 21097774)
1. Colorectal cancer susceptibility loci on chromosome 8q23.3 and 11q23.1 as modifiers for disease expression in Lynch syndrome.
Talseth-Palmer BA; Brenne IS; Ashton KA; Evans TJ; McPhillips M; Groombridge C; Suchy J; Kurzawski G; Spigelman A; Lubinski J; Scott RJ
J Med Genet; 2011 Apr; 48(4):279-84. PubMed ID: 21097774
[TBL] [Abstract][Full Text] [Related]
2. Combined analysis of three Lynch syndrome cohorts confirms the modifying effects of 8q23.3 and 11q23.1 in MLH1 mutation carriers.
Talseth-Palmer BA; Wijnen JT; Brenne IS; Jagmohan-Changur S; Barker D; Ashton KA; Tops CM; Evans TJ; McPhillips M; Groombridge C; Suchy J; Kurzawski G; ; Spigelman A; Møller P; Morreau HM; Van Wezel T; Lubinski J; Vasen HF; Scott RJ
Int J Cancer; 2013 Apr; 132(7):1556-64. PubMed ID: 22987364
[TBL] [Abstract][Full Text] [Related]
3. Chromosome 8q23.3 and 11q23.1 variants modify colorectal cancer risk in Lynch syndrome.
Wijnen JT; Brohet RM; van Eijk R; Jagmohan-Changur S; Middeldorp A; Tops CM; van Puijenbroek M; Ausems MG; Gómez García E; Hes FJ; Hoogerbrugge N; Menko FH; van Os TA; Sijmons RH; Verhoef S; Wagner A; Nagengast FM; Kleibeuker JH; Devilee P; Morreau H; Goldgar D; Tomlinson IP; Houlston RS; van Wezel T; Vasen HF
Gastroenterology; 2009 Jan; 136(1):131-7. PubMed ID: 19010329
[TBL] [Abstract][Full Text] [Related]
4. Susceptibility genetic variants associated with early-onset colorectal cancer.
Giráldez MD; López-Dóriga A; Bujanda L; Abulí A; Bessa X; Fernández-Rozadilla C; Muñoz J; Cuatrecasas M; Jover R; Xicola RM; Llor X; Piqué JM; Carracedo A; Ruiz-Ponte C; Cosme A; Enríquez-Navascués JM; Moreno V; Andreu M; Castells A; Balaguer F; Castellví-Bel S;
Carcinogenesis; 2012 Mar; 33(3):613-9. PubMed ID: 22235025
[TBL] [Abstract][Full Text] [Related]
5. Are the common genetic variants associated with colorectal cancer risk for DNA mismatch repair gene mutation carriers?
Win AK; Hopper JL; Buchanan DD; Young JP; Tenesa A; Dowty JG; Giles GG; Goldblatt J; Winship I; Boussioutas A; Young GP; Parry S; Baron JA; Duggan D; Gallinger S; Newcomb PA; Haile RW; Le Marchand L; Lindor NM; Jenkins MA
Eur J Cancer; 2013 May; 49(7):1578-87. PubMed ID: 23434150
[TBL] [Abstract][Full Text] [Related]
6. SNP association study in PMS2-associated Lynch syndrome.
Ten Broeke SW; Elsayed FA; Pagan L; Olderode-Berends MJW; Garcia EG; Gille HJP; van Hest LP; Letteboer TGW; van der Kolk LE; Mensenkamp AR; van Os TA; Spruijt L; Redeker BJW; Suerink M; Vos YJ; Wagner A; Wijnen JT; Steyerberg EW; Tops CMJ; van Wezel T; Nielsen M
Fam Cancer; 2018 Oct; 17(4):507-515. PubMed ID: 29147930
[TBL] [Abstract][Full Text] [Related]
7. Enrichment of low penetrance susceptibility loci in a Dutch familial colorectal cancer cohort.
Middeldorp A; Jagmohan-Changur S; van Eijk R; Tops C; Devilee P; Vasen HF; Hes FJ; Houlston R; Tomlinson I; Houwing-Duistermaat JJ; Wijnen JT; Morreau H; van Wezel T
Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):3062-7. PubMed ID: 19843678
[TBL] [Abstract][Full Text] [Related]
8. DNA repair gene polymorphisms and risk of early onset colorectal cancer in Lynch syndrome.
Reeves SG; Meldrum C; Groombridge C; Spigelman A; Suchy J; Kurzawski G; Lubinski J; Scott RJ
Cancer Epidemiol; 2012 Apr; 36(2):183-9. PubMed ID: 21974800
[TBL] [Abstract][Full Text] [Related]
9. Clinical relevance of 8q23, 15q13 and 18q21 SNP genotyping to evaluate colorectal cancer risk.
Baert-Desurmont S; Charbonnier F; Houivet E; Ippolito L; Mauillon J; Bougeard M; Abadie C; Malka D; Duffour J; Desseigne F; Colas C; Pujol P; Lejeune S; Dugast C; Buecher B; Faivre L; Leroux D; Gesta P; Coupier I; Guimbaud R; Berthet P; Manouvrier S; Cauchin E; Prieur F; Laurent-Puig P; Lebrun M; Jonveaux P; Chiesa J; Caron O; Morin-Meschin ME; Polycarpe-Osaer F; Giraud S; Zaanan A; Bonnet D; Mansuy L; Bonadona V; El Chehadeh S; Duhoux F; Gauthier-Villars M; Saurin JC; Collonge-Rame MA; Brugières L; Wang Q; Bressac-de Paillerets B; Rey JM; Toulas C; Buisine MP; Bronner M; Sokolowska J; Hardouin A; Cailleux AF; Sebaoui H; Blot J; Tinat J; Benichou J; Frebourg T
Eur J Hum Genet; 2016 Jan; 24(1):99-105. PubMed ID: 25873010
[TBL] [Abstract][Full Text] [Related]
10. Association studies on 11 published colorectal cancer risk loci.
von Holst S; Picelli S; Edler D; Lenander C; Dalén J; Hjern F; Lundqvist N; Lindforss U; Påhlman L; Smedh K; Törnqvist A; Holm J; Janson M; Andersson M; Ekelund S; Olsson L; Ghazi S; Papadogiannakis N; Tenesa A; Farrington SM; Campbell H; Dunlop MG; Lindblom A
Br J Cancer; 2010 Aug; 103(4):575-80. PubMed ID: 20648012
[TBL] [Abstract][Full Text] [Related]
11. Colorectal cancer risk variants at 8q23.3 and 11q23.1 are associated with disease phenotype in APC mutation carriers.
Ghorbanoghli Z; Nieuwenhuis MH; Houwing-Duistermaat JJ; Jagmohan-Changur S; Hes FJ; Tops CM; Wagner A; Aalfs CM; Verhoef S; Gómez García EB; Sijmons RH; Menko FH; Letteboer TG; Hoogerbrugge N; van Wezel T; Vasen HF; Wijnen JT
Fam Cancer; 2016 Oct; 15(4):563-70. PubMed ID: 26880076
[TBL] [Abstract][Full Text] [Related]
12. Relationship between 16 susceptibility loci and colorectal cancer phenotype in 3146 patients.
Lubbe SJ; Whiffin N; Chandler I; Broderick P; Houlston RS
Carcinogenesis; 2012 Jan; 33(1):108-12. PubMed ID: 22045029
[TBL] [Abstract][Full Text] [Related]
13. Colorectal cancer susceptibility loci in a population-based study: Associations with morphological parameters.
Ghazi S; von Holst S; Picelli S; Lindforss U; Tenesa A; Farrington SM; Campbell H; Dunlop MG; Papadogiannakis N; Lindblom A;
Am J Pathol; 2010 Dec; 177(6):2688-93. PubMed ID: 21119214
[TBL] [Abstract][Full Text] [Related]
14. Contribution of the MLH1 -93G>a promoter polymorphism in modulating susceptibility risk in Malaysian colorectal cancer patients.
Nizam ZM; Abdul Aziz AA; Kaur G; Abu Hassan MR; Mohd Sidek AS; Yeh LY; Mazuwin M; Ankathil R
Asian Pac J Cancer Prev; 2013; 14(2):619-24. PubMed ID: 23621208
[TBL] [Abstract][Full Text] [Related]
15. Is the reported modifying effect of 8q23.3 and 11q23.1 on colorectal cancer risk for MLH1 mutation carriers valid?
Win AK; Jenkins MA
Int J Cancer; 2013 Oct; 133(7):1762-3. PubMed ID: 23536426
[No Abstract] [Full Text] [Related]
16. One to 2-year surveillance intervals reduce risk of colorectal cancer in families with Lynch syndrome.
Vasen HF; Abdirahman M; Brohet R; Langers AM; Kleibeuker JH; van Kouwen M; Koornstra JJ; Boot H; Cats A; Dekker E; Sanduleanu S; Poley JW; Hardwick JC; de Vos Tot Nederveen Cappel WH; van der Meulen-de Jong AE; Tan TG; Jacobs MA; Mohamed FL; de Boer SY; van de Meeberg PC; Verhulst ML; Salemans JM; van Bentem N; Westerveld BD; Vecht J; Nagengast FM
Gastroenterology; 2010 Jun; 138(7):2300-6. PubMed ID: 20206180
[TBL] [Abstract][Full Text] [Related]
17. Characterization of gene-environment interactions for colorectal cancer susceptibility loci.
Hutter CM; Chang-Claude J; Slattery ML; Pflugeisen BM; Lin Y; Duggan D; Nan H; Lemire M; Rangrej J; Figueiredo JC; Jiao S; Harrison TA; Liu Y; Chen LS; Stelling DL; Warnick GS; Hoffmeister M; Küry S; Fuchs CS; Giovannucci E; Hazra A; Kraft P; Hunter DJ; Gallinger S; Zanke BW; Brenner H; Frank B; Ma J; Ulrich CM; White E; Newcomb PA; Kooperberg C; LaCroix AZ; Prentice RL; Jackson RD; Schoen RE; Chanock SJ; Berndt SI; Hayes RB; Caan BJ; Potter JD; Hsu L; Bézieau S; Chan AT; Hudson TJ; Peters U
Cancer Res; 2012 Apr; 72(8):2036-44. PubMed ID: 22367214
[TBL] [Abstract][Full Text] [Related]
18. Risk and epidemiological time trends of gastric cancer in Lynch syndrome carriers in the Netherlands.
Capelle LG; Van Grieken NC; Lingsma HF; Steyerberg EW; Klokman WJ; Bruno MJ; Vasen HF; Kuipers EJ
Gastroenterology; 2010 Feb; 138(2):487-92. PubMed ID: 19900449
[TBL] [Abstract][Full Text] [Related]
19. Generalizability and epidemiologic characterization of eleven colorectal cancer GWAS hits in multiple populations.
He J; Wilkens LR; Stram DO; Kolonel LN; Henderson BE; Wu AH; Le Marchand L; Haiman CA
Cancer Epidemiol Biomarkers Prev; 2011 Jan; 20(1):70-81. PubMed ID: 21071539
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide association scan identifies a colorectal cancer susceptibility locus on 11q23 and replicates risk loci at 8q24 and 18q21.
Tenesa A; Farrington SM; Prendergast JG; Porteous ME; Walker M; Haq N; Barnetson RA; Theodoratou E; Cetnarskyj R; Cartwright N; Semple C; Clark AJ; Reid FJ; Smith LA; Kavoussanakis K; Koessler T; Pharoah PD; Buch S; Schafmayer C; Tepel J; Schreiber S; Völzke H; Schmidt CO; Hampe J; Chang-Claude J; Hoffmeister M; Brenner H; Wilkening S; Canzian F; Capella G; Moreno V; Deary IJ; Starr JM; Tomlinson IP; Kemp Z; Howarth K; Carvajal-Carmona L; Webb E; Broderick P; Vijayakrishnan J; Houlston RS; Rennert G; Ballinger D; Rozek L; Gruber SB; Matsuda K; Kidokoro T; Nakamura Y; Zanke BW; Greenwood CM; Rangrej J; Kustra R; Montpetit A; Hudson TJ; Gallinger S; Campbell H; Dunlop MG
Nat Genet; 2008 May; 40(5):631-7. PubMed ID: 18372901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
